Cancer Radiotherapy: A Treatment Option in the Very Old (80+) (69201)
Session Chair: Oliver Micke
Saturday, 1 April 2023 16:50
Session: Session 4
Room: Room 707
Presentation Type:Oral Presentation
There are only very few clinical data regarding radiotherapy (RT) in elderly patients. We present a retrospective study of all patients aged 80 years and older who underwent RT with external beam irradiation in our institution in the years 2020 and 2021. Overall, there were 163 patients treated with 196 courses of RT. The mean age was 84 years (range: 80–99 years). A total of 97 patients (59%) were male. The treatment intent was palliative in 41% and curative in 59%. The primary cancer diagnoses were: prostate 46, lung 18, breast 25, head and neck 10, gastrointestinal 8, hematologic 7, gynecologic 11, skin 18, genitourinary 9, unknown primary 5, central nervous system 6. The patients were able to complete the prescribed therapy in 153 of 196 courses (78%). Treatment breaks during RT were only required in 54 (33%) of Rt courses. RT can be safely administered to an elderly population with both curative and palliative intent with the expectation of completion in more than 80% of patients. The reasons for inability to complete RT as prescribed are multifactorial, but careful patient selection and attention to comorbidity may optimize the outcome.
Authors:
Oliver Micke, Franziskus Hospital Bielefeld, Germany
About the Presenter(s)
Professor Oliver Micke is a University Assistant Professor/Lecturer at Franziskus Hospital Bielefeld in Germany. His research interests are radiation oncology, complementary medicine, trace elements and electrolytes.
Connect on ResearchGate
https://www.researchgate.net/profile/Oliver-Micke
See this presentation on the full schedule – Saturday Schedule
Comments
Powered by WP LinkPress